Algocell Secures $2.8M in Pre-Seed Funding to Optimize Bioprocessing with AI

Israeli startup Algocell has secured $2.8 million in pre-seed funding to advance its AI-driven platform for optimizing bioprocess development in industries like cultivated meat, precision fermentation, biofuels, and cosmetics. Their Digital Twin platform uses machine learning models to enhance experimentation speed, process control, and product consistency, even with limited datasets. CEO Omri Schanin emphasized the company's goal of data-driven decisions, targeted experiments, and optimized processes for efficient cell-based manufacturing.

With the funding, Algocell plans to expand its team and improve the platform's predictive capabilities to launch commercial pilot programs with manufacturers across various sectors. By addressing key challenges in bioprocessing, such as cost reduction and technology transfer hurdles, Algocell aims to accelerate the commercialization of emerging biotechnologies and lower production costs. Good Company VC's Arnaud Lorie, who will join Algocell's board of directors, expressed confidence in the founders' clarity, grit, and long-term mindset, highlighting the company's potential in the industry.